Publication | Closed Access
A unique amidoanthraquinone derivative displays antiproliferative activity against human hormone-refractory metastatic prostate cancers through activation of LKB1-AMPK-mTOR signaling pathway
12
Citations
26
References
2014
Year
UrologyMedicinePharmacotherapyAnti-cancer AgentCancer TreatmentProstatic DiseasePharmacologyEndocrine-related CancerDrug Discovery
| Year | Citations | |
|---|---|---|
Page 1
Page 1